Results 91 to 100 of about 16,080 (220)

Intravitreal dexamethasone implant migration to the anterior chamber in an aphakic child

Vision Pan-America, 2013
An 8-year-old girl, who underwent pars plana lensectomy and vitrectomy for non-infectious uveitis, was treated with a dexamethasone intravitreal implant (Ozurdex®, Allergan Inc., Irvine CA), because of the persistence of cystoid macular edema ...
Lourdes de Juan-Marcos, Luciá Cabrillo-Esteves, Victoria Losada-Burgos, Emiliano Hernandéz-Galilea   +3 more
doaj   +1 more source

Management of Mixed Mechanism Glaucoma Secondary to NewColorIris Implant Using an Ab Externo Xen Gel Stent

Case Reports in Ophthalmological Medicine, Volume 2026, Issue 1, 2026.
Background and Aims We present a case of mixed mechanism glaucoma following NewColorIris implant that was successfully treated using an off‐label use of Xen Gel Stent. Methods A retrospective review of the patient′s medical records was conducted following the acquisition of informed consent.
Roshun Sangani, Param Shukla, Miriam M. Habiel, Karuna Sharma   +3 more
wiley   +1 more source

Posterior Sub-Tenon Triamcinolone Injection for Chronic Macular Oedema Associated With Non-Ischemic Branch or Central Retinal Vein Occlusion [PDF]

, 2016
Aims: To evaluate the effectiveness and safety of Posterior Sub-Tenon (PST) Triamcinolone Acetonide (TA) injection for persistent macular oedema associated with non-ischemic Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO) in
Aude Ambresin, Hoai Viet Tran, Iris Sabani, Jean-Antoine Pournaras, null null, null null, null null, null null, null null, Thomas J. Wolfensberger   +9 more
core   +1 more source

Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention [PDF]

, 2016
Hereditary retinal diseases are now the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales, of which retinitis pigmentosa (RP) is the most common disorder.
Liew, G, Michaelides, M, Strong, S
core   +1 more source

Ocriplasmin in the treatment of vitreomacular traction in a patient with central retinal vein occlusion. a case report [PDF]

, 2018
Aim: To investigate the efficacy of intravitreal injection of ocriplasmin (JETREA®) in the treat-ment of vitreomacular traction (VMT). Materials and Methods: An 81-year-old man with VMT associated with central retinal vein occlusion in his left eye, was ...
Antonio Esposito, Raffaele, Mannino, Giuseppe, Rosati, Alessandra, Scuderi, Gianluca   +3 more
core   +2 more sources

Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia

Journal of Ophthalmic Inflammation and Infection
Purpose To report the use of Fluocinolone intravitreal implant (Iluvien) for the treatment of persistent cystoid macular edema (CME) due to immune recovery uveitis syndrome in a patient with previous cytomegalovirus retinitis and acute myeloid leukemia ...
JM Cachero Rodríguez, J. Artaraz, Nora Imaz, A. Fonollosa   +3 more
doaj   +1 more source

Cystoid Macular Edema in Bietti's Crystalline Retinopathy

Case Reports in Ophthalmological Medicine, 2014
A 27-year-old man with progressive bilateral visual decline was diagnosed to have Bietti's crystalline dystrophy (BCD). Fluorescein angiography revealed bilateral petaloid type late hyperfluorescence implicating concurrent cystoid macular edema (CME ...
Ali Osman Saatci, Hasan Can Doruk, Aylin Yaman   +2 more
doaj   +1 more source

Autofluorescence Imaging for Diagnosis and Follow-up of Cystoid Macular Edema

Journal of Ophthalmic & Vision Research, 2012
Lipofuscin results from digestion of photoreceptor outer segments by the retinal pigment epithelium (RPE) and is the principal compound that causes RPE fluorescence during autofluorescence imaging.
Nazanin Ebrahimiadib, Mohammad Riazi-Esfahani   +1 more
doaj  

Fingolimod: therapeutic mechanisms and ocular adverse effects. [PDF]

, 2017
Fingolimod is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). We aim to review the published literature on ocular manifestations of fingolimod therapy and their possible underlying mechanisms.
A Groves, A Gupta, A Minuk, A Schwarz, AR Afshar, B Nealon, BJ McVerry, C Aguiar, D Ontaneda, G Saab, H Chen, H Tedesco-Silva, J Camm, J Chui, J Chun, JA Cohen, JA Cohen, JM Gelfand, K Schroder, K Turaka, L Kappos, L Kappos, L Liu, M Brar, M Salvadori, MA Zarbin, ML Oo, MT Bhatti, N Ueda, OJ Coppes, P A Keane, P Mandal, PA Calabresi, R Gallego-Pinazo, R Moosavi, RS Brush, S Thoo, V Li, VM Asensio-Sanchez, W Fusi-Rubiano, Y Yang   +40 more
core   +1 more source

Optical Coherence Tomography of Adult-Onset Foveomacular Vitelliform Dystrophy Concomitant with Diabetic Cystoid Macular Edema

Delhi Journal of Ophthalmology, 2019
Purpose: To report an unusual appearance on Spectralis optical coherence tomography (OCT) finding: bilateral adult-onset foveomacular vitelliform dystrophy (AFVD) concomitant with diabetic cystoid macular edema.
Kemal Tekin, Mehmet Murat Uzel, Mehmet Yasin Teke   +2 more
doaj   +1 more source